Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Rituximab for autoimmune haemophilia: a proposed treatment algorithm.

Aggarwal A, Grewal R, Green RJ, Boggio L, Green D, Weksler BB, Wiestner A, Schechter GP.

Haemophilia. 2005 Jan;11(1):13-9. Review.

PMID:
15660983
2.

Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis.

Franchini M, Mengoli C, Lippi G, Targher G, Montagnana M, Salvagno GL, Zaffanello M, Cruciani M.

Haemophilia. 2008 Sep;14(5):903-12. doi: 10.1111/j.1365-2516.2008.01839.x. Epub 2008 Jul 28. Review.

PMID:
18671801
3.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
4.

Inhibitor eradication with rituximab in haemophilia: where do we stand?

Franchini M, Mannucci PM.

Br J Haematol. 2014 Jun;165(5):600-8. doi: 10.1111/bjh.12829. Epub 2014 Mar 15. Review.

PMID:
24628543
5.

The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.

D'arena G, Grandone E, Di Minno MN, Musto P, Di Minno G.

Blood Transfus. 2016 May;14(2):255-61. doi: 10.2450/2015.0090-15. Epub 2015 Sep 3. Review.

6.

Rituximab for the treatment of acquired antibodies to factor VIII.

Sperr WR, Lechner K, Pabinger I.

Haematologica. 2007 Jan;92(1):66-71. Review.

7.

Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia.

Tay L, Duncan E, Singhal D, Al-Qunfoidi R, Coghlan D, Jaksic W, Szabo F, McRae S, Lloyd J.

Semin Thromb Hemost. 2009 Nov;35(8):769-77. doi: 10.1055/s-0029-1245109. Epub 2010 Feb 18. Review.

PMID:
20169513
9.

Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.

Alvarado Y, Yao X, Jumper C, Hardwicke F, D'Cunha N, Cobos E.

Clin Appl Thromb Hemost. 2007 Oct;13(4):443-8. Review.

PMID:
17911199
10.

Acquired haemophilia syndrome: pathophysiology and therapy.

Elezović I.

Srp Arh Celok Lek. 2010 Jan;138 Suppl 1:64-8. Review.

11.

Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature.

Muzaffar J, Katragadda L, Haider S, Javed A, Anaissie E, Usmani S.

Int J Hematol. 2012 Jan;95(1):102-6. doi: 10.1007/s12185-011-0968-7. Epub 2011 Dec 15. Review.

PMID:
22170228
12.

Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B--a systematic literature review.

Laros-van Gorkom BA, Falaise C, Astermark J.

Eur J Haematol Suppl. 2014 Aug;76:26-38. doi: 10.1111/ejh.12372. Review.

PMID:
24957105
13.

Rituximab in the treatment of adult acquired hemophilia A: a systematic review.

Franchini M.

Crit Rev Oncol Hematol. 2007 Jul;63(1):47-52. Epub 2007 Jan 19. Review.

PMID:
17236786
15.

[Cold agglutinin disease -  no response to glucocorticoids and rituximab, what treatment is best for the 3rd line of therapy? Case report and review of the literature].

Adam Z, Pejchalová A, Chlupová G, Ríhová L, Pour L, Krejčí M, Cervinek L, Král Z, Mayer J.

Vnitr Lek. 2013 Sep;59(9):828-40. Review. Czech.

PMID:
24073955
16.

Acquired inhibitors.

Cohen AJ, Kessler CM.

Baillieres Clin Haematol. 1996 Jun;9(2):331-54. Review.

PMID:
8800509
17.

Rituximab in the treatment of autoimmune haematological disorders.

Garvey B.

Br J Haematol. 2008 Apr;141(2):149-69. doi: 10.1111/j.1365-2141.2008.07054.x. Epub 2008 Mar 3. Review.

18.

Anti-glomerular basement membrane antibody disease treated with rituximab: A case-based review.

Syeda UA, Singer NG, Magrey M.

Semin Arthritis Rheum. 2013 Jun;42(6):567-72. doi: 10.1016/j.semarthrit.2012.10.007. Epub 2013 Jan 24. Review.

PMID:
23352254

Supplemental Content

Support Center